Trials / Completed
CompletedNCT02681315
Comparison of Two Flow Rates of HHHFNC to Prevent Extubation Failure in Preterm Infants
HHHFNC to Prevent Extubation Failure in Preterm Infants: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Mansoura University Children Hospital · Academic / Other
- Sex
- All
- Age
- 1 Hour – 30 Days
- Healthy volunteers
- Not accepted
Summary
This is a randomized controlled trial (RCT) to evaluate the influence of two flow rates (6 liter/min versus 3 liter/min) of Heated-Humidified High-Flow-Nasal-Cannula (HHHFNC) on rates of extubation failure in mechanically ventilated preterm infants.
Detailed description
HHHFNC has been proposed as an alternative to nasal continuous positive airway pressure (nCPAP) in neonatal intensive care units (NICUs) for preventing extubation failure. In a recent international survey on periextubation practices in extremely preterm infants, nCPAP was the most common type of respiratory support used (84%) followed by nasal intermittent positive pressure ventilation (55%) and HHHFNC (33%). Moreover, HHHFNC appears to have efficacy and safety similar to those of nCPAP when applied immediately post-extubation to prevent extubation failure in preterm infants. and resulted in significantly less nasal trauma in the first 7 days post-extubation than nCPAP. However, the best flow rates of HHHFNC to prevent extubation failure remains to be known. This RCT aims to compare the efficacy and safety of postextubation respiratory support via HHHFNC at two different flow rates (6 L/min. versus 3 L/min) regarding successful extubation after a period of endotracheal positive pressure ventilation. We hypothesized that postextubation respiratory support via HHHFNC at a flow rate of 6 L/min. will result in a greater proportion of preterm infants being successfully extubated after a period of endotracheal positive pressure ventilation compared with HHHFNC at a flow rate of 3 L/min.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HHHFNC 6 liter minute | Infants allocated to HHHFNC at 6 L/min. will be extubated to a HHHFNC flow of 6 L/min. Eligible infants will be enrolled while receiving mechanical ventilation. The timing of extubation will be determined by the clinical team and all infants will start caffeine prior to extubation. |
| DEVICE | HHHFNC 3 liters/min | Infants allocated to HHHFNC at 3 L/min. will be extubated to a HHHFNC flow of 3 L/min. Eligible infants will be enrolled while receiving mechanical ventilation. The timing of extubation will be determined by the clinical team and all infants will start caffeine prior to extubation. |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2016-02-12
- Last updated
- 2020-02-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02681315. Inclusion in this directory is not an endorsement.